The Healthy on MSN6h
“Here’s What Happened When I Stopped Taking Ozempic”: One Patient’s Story Navigating a New Normal
Did she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who ...
Embecta Corp.: Navigating Through A Changing Landscape
Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...
RIPR: The Public's Radio20h
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.
FTC lawsuit claims drug middlemen are manipulating insulin market
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...